MedPath

A study on the effects of culture supernatant of human somatic stem cells on liver cirrhosis

Phase 1
Conditions
iver cirrhosis
Registration Number
JPRN-UMIN000014211
Lead Sponsor
Shin-yurigaoka General Hospital
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete: follow-up complete
Sex
All
Target Recruitment
6
Inclusion Criteria

Not provided

Exclusion Criteria

-Patients with malignant diseases -patients with hepatic coma -Patients with serum Cr >= 2mg/dl -Patients with HIV infection -Patients with autoimmune diseases -Patients who had bleeding from esophageal or gastric varices within the previous 3 months -Patients with severe organ dysfunction -Patients infected with unknown microbe

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath